EXCLUSIVE: Ambrosia, the Young Blood Transfusion Startup, Is Quietly Back in Business

The company says it paused operations after an FDA notice, but customer demand remained high

Emily Mullin
OneZero
Published in
4 min readNov 8, 2019

--

Credit: picture alliance/Getty Images

EEarlier this year, Ambrosia, the much-maligned California startup selling blood transfusions from young donors, stopped offering the procedure after the U.S. Food and…

--

--

Emily Mullin
OneZero

Former staff writer at Medium, where I covered biotech, genetics, and Covid-19 for OneZero, Future Human, Elemental, and the Coronavirus Blog.